1
Training Program on
Complaints, Recall, Rejection & Re-Process of
Material
2
Complaints, Recall, Rejection & Re-Process of Material
Complaints, Recall, Rejection & Re-Process of Material: Applicable Guidelines
ICH HARMONISED TRIPARTITE GUIDELINE
GOOD MANUFACTURING PRACTICE GUIDE FOR
ACTIVE PHARMACEUTICAL INGREDIENTS
Q7
3
Complaints, Recall, Rejection & Re-Process of Material
Scope:
The scope of this presentation is to address the Complaints, Recall, Rejection
& Re-Process & Rework of Material.
4
Complaints, Recall, Rejection & Re-Process of Material
Regulatory Prospective:
ICH Q7
A
t Coral Drugs Pvt Ltd
Section 2.2
Quality unit should be responsible for making sure
that quality related complaints are investigated and
resolved.
Quality assurance is responsible for overall
implementation of complaint
SOP #CDPL/SO/QA/009/10 , involve in investigation,
suggest CAPA, adequately close and resolve the
complaint.
5
Complaints, Recall, Rejection & Re-Process of Material
ICH Q7
A
t Coral Drugs Pvt Ltd
Section 2.5
Product Quality Review
A review of all quality
-related returns, complaints
and recalls.
Market complaints and return are reviewed during
product quality review. Refer section 6.2
SOP# CDPL/SOP/QA/019/06
Regulatory Prospective:
6
Complaints, Recall, Rejection & Re-Process of Material
ICH Q7
A
t Coral Drugs Pvt Ltd
Section 10.11
Separate storage area should be assigned to
returned or recalled material.
Returned goods should be kept in designated
rejected area by maintaining proper storage
condition.
Refer section 4.1
SOP# CDPL/SOP/QA/049/05
Recall material must be kept in rejected room under
lock and key.
Refer section 4.1
SOP# CDPL/SOP/QA/012/07
Regulatory Prospective:
7
Complaints, Recall, Rejection & Re-Process of Material
ICH Q7
A
t Coral Drugs Pvt Ltd
Section 11.11
There should be documented procedures
describing sampling, testing, approval or
rejection of materials.
Rejection of material is handled to through
SOP# CDPL/SOP/QC/024/10
Regulatory Prospective:
8
Complaints, Recall, Rejection & Re-Process of Material
ICH Q7
A
t Coral Drugs Pvt Ltd
Section 14.20
Introduction an intermediate or API, including one
that does not conform to standards or specifications,
back into process and reprocessing by repeating a
crystallization step or other appropriate chemical or
physical manipulation steps (e.g. distillation, filtration,
milling) that are part of established manufacturing
process is considered acceptable for reprocessing.
Reprocess is, introducing an intermediate or API,
back into the process and repeating a crystallization
step or other appropriate chemical and physical
manipulation steps (e.g. distillation, filtration,
column) that are part of the established
manufacturing process. (Section 6.1)
SOP# CDPL/SOP/QA/027/08
Regulatory Prospective:
9
Complaints, Recall, Rejection & Re-Process of Material
ICH Q7
A
t Coral Drugs Pvt Ltd
Section 14.3
Before a decision is taken to rework batches that do
not confirm to established specifications, an
investigation should be performed.
Any batch of intermediate or finished product is
rejected, after investigation and decision is made to
rework the batch. (Section 6.2.1 & Section 6.2.2)
SOP# CDPL/SOP/QA/048/04
Regulatory Prospective:
10
Complaints, Recall, Rejection & Re-Process of Material
ICH Q7
A
t Coral Drugs Pvt Ltd
Section 14.31
Batch that have reworked should be subject to
appropriate evaluation, testing, stability testing if
warranted.
If there is only one batch to be reworked, then report
can be written and the batch released once it is found
to be acceptable.
The rework batches may be released for commercial
purpose, if quality of such batches is similar to the
normal production batches and results of stability
If there is one batch to be reworked then interim
report will be prepared and the batch released, if it is
acceptable (Section 6.2.10 & Section 6.2.13)
SOP# CDPL/SOP/QA/048/04
Regulatory Prospective:
11
Complaints, Recall, Rejection & Re-Process of Material
ICH Q7
A
t Coral Drugs Pvt Ltd
Section 14.32
Procedures should provide for comparing the impurity
profile of each reworked batch against batches
manufactured by established. Where routine analytical
methods are inadequate to characterize the reworked
batch, additional method should be used.
Impurity profile of re
-worked batches shall be
compared with validation batches. Quality control will
supports any additional testing required to ensure
integrity of the reworked material. (Section 6.2.13 &
Section 6.2.14)
SOP# CDPL/SOP/QA/048/04
Regulatory Prospective:
12
Complaints, Recall, Rejection & Re-Process of Material
ICH Q7
A
t Coral Drugs Pvt Ltd
Section 14.50
Returned intermediates or APIs should be identified as
such and quarantined.
Return goods should be kept in designated rejected
area by maintaining proper storage condition.
(Section 4.1)
SOP# CDPL/SOP/QA/049/05
Regulatory Prospective:
13
Complaints, Recall, Rejection & Re-Process of Material
ICH Q7
A
t Coral Drugs Pvt Ltd
Section 14.51
If the conditions under which returned intermediates
or APIs have been stored or shipped before or during
their return or the condition of their containers casts
doubt on their quality, the returned intermediates or
APIs should be reprocessed, reworked, or destroyed,
as appropriate.
Based on the condition of the material/drums, QA will
decide suitable recommendation. (Section 6.7)
SOP# CDPL/SOP/QA/049/05
Regulatory Prospective:
14
Complaints, Recall, Rejection & Re-Process of Material
ICH Q7
A
t Coral Drugs Pvt Ltd
Section 15.10
All quality related complaints whether received orally
or in writing, should be recorded and investigated
accordingly to a written procedure.
Based on the condition of the material/drums, QA will
decide suitable recommendation. (Section 6.7)
SOP# CDPL/SOP/QA/049/05
Regulatory Prospective:
15
Complaints, Recall, Rejection & Re-Process of Material
ICH Q7
A
t Coral Drugs Pvt Ltd
Section 15.11
Complaint records should include:
Name and address of complaint
Name (and, where appropriate, title) and phone
number of person submitting the complaint;
Complaint nature (including name and batch number
of the API)
Date compliant is received.
Name and address, title, complaint nature, date of
complaint, are recorded on Format No.
CDPL/FR/QA/112
SOP# CDPL/SOP/QA/009/10
Regulatory Prospective:
16
Complaints, Recall, Rejection & Re-Process of Material
ICH Q7
A
t Coral Drugs Pvt Ltd
Section 15.11
Action initially taken (including dates and identity of
person taking the action);
Any follow
-up action taken
Response provided to the originator of complaint
(including date response sent) and
Final decision on intermediate or API batch or lot.
Action initially taken are recorded on Format No.
CDPL/FR/QA/111
SOP# CDPL/SOP/QA/009/10
Regulatory Prospective:
17
Complaints, Recall, Rejection & Re-Process of Material
ICH Q7
A
t Coral Drugs Pvt Ltd
Section 15.13
There should be written procedure that defines the
circumstances under which a recall of an intermediate
or API should be considered.
Procedure for Recall SOP# CDPL/SOP/QA/012/07 is
established that define the circumstances under
which a recall of an intermediate is initiated.
(Section 6.1)
Regulatory Prospective:
18
Complaints, Recall, Rejection & Re-Process of Material
ICH Q7
A
t Coral Drugs Pvt Ltd
Section 15.14
The recall procedure should designate who should be
involved in evaluating the information, how a recall
should be initiated, who should be informed about
recall, and how the recall material should be treated.
Procedure for Recall SOP# CDPL/SOP/QA/012/07 is
established that describe the responsibility complete
information on recall.
Regulatory Prospective:
19
Complaints, Recall, Rejection & Re-Process of Material
Customer complaints….!!!
(SOP#CDPL/SOP/QA/009/10)
20
Complaints, Recall, Rejection & Re-Process of Material
Head-QA/ Designee shall write the complaint product details and categorize the complaint as
Critical/Major/Minor .
Critical Complaint:
A complaint that strongly indicates the purity, identity, safety or efficacy of a product may have been
compromised and has the potential to cause a life threatening or serious health situation.
Major Complaint:
A complaint that indicates the purity, identity, safety or efficacy of a product may have been
compromised but does not present as a life threatening or serious health risk.
Minor Complaint:
A complaint that is neither critical nor serious.
Complaint Category
21
Complaints, Recall, Rejection & Re-Process of Material
Based on Preliminary investigation, response shall be sent to the customer with in 15 days.
Close out of the complaint with complete investigation shall be made within 45 days.
Incase the investigation time extends beyond the closer time frame, it will be informed to the
customer and justified.
If customer did not responds within 90 days after getting the investigation report, complaint will be
considered as closed thereafter.
Closure Time Frame
22
Complaints, Recall, Rejection & Re-Process of Material
Recall Procedure ….!!!
(SOP#CDPL/SOP/QA/012/07)
23
Complaints, Recall, Rejection & Re-Process of Material
Based on the evaluation, the recall team members shall classify the recall as Class I, Class II and Class III.
Class I Recall:
These are recalls which result from quality defects of medicinal products which are potentially life
threatening or could cause serious risk to health.
Class II Recall:
These are recalls due to quality defects which may cause mistreatment or harm to the patient but it is not
life threatening or serious.
Class III Recall:
These are recalls due to quality defects which are unlikely to cause harm to the patient, and the pose a
significant hazard to health but where a recall has been initiated for other reasons, such as noncompliance
with the marketing authorization or specification.
Recall Classification
24
Complaints, Recall, Rejection & Re-Process of Material
Based on the category of risks involved; specific time line is assigned for recall of the product:
Within 24 hour up to a maximum of 72 hours for class I recall
Up to a maximum of 72 hours for Class I recall
Up to maximum of 10 days for Class II recall
Up to maximum of 30 days for Class III recall
Time lines for effective Recall system
25
Complaints, Recall, Rejection & Re-Process of Material
Return Goods ….!!!
(SOP#CDPL/SOP/QA/049/05)
26
Complaints, Recall, Rejection & Re-Process of Material
Returned intermediates or APIs should be identified as such and Rejection.
If the conditions under which returned intermediates or APIs have been stored or shipped before or
during their return or the condition of their containers casts doubt on their quality, the returned
intermediates or APIs should be reprocessed, reworked or destroyed, as appropriate.
Records of returned intermediates or APIs should be maintained. For each return documentation should
include:
Name & address of the consignee.
Intermediate or API, batch number and quantity returned.
Reason for return.
Use or disposal of the returned intermediate or API.
Store department shall inform to Quality Assurance through “Return Goods
Handling form” on applicable format.
Returned API shall be handled through return goods procedure.
Return Goods:
27
Complaints, Recall, Rejection & Re-Process of Material
Reprocess Procedure ….!!!
(SOP#CDPL/SOP/QA/027/08)
28
Complaints, Recall, Rejection & Re-Process of Material
Reprocess is, introducing an intermediate or API, back into the process and repeating a crystallization step
or other appropriate chemical or physical manipulation steps (e.g. distillation, filtration, column) that are
part of the established manufacturing process.
Reprocess:
29
Complaints, Recall, Rejection & Re-Process of Material
Reprocessing of intermediate / finished product shall be applicable in following conditions:
Manufacturing older than 6 months
To meet the customer special requirements.
Recommendations after investigation of return goods.
Recommendation from OOS
For making a homogenous batch of tailing batches quantity available in finished good store.
Conditions for Reprocessing of Intermediates/Finished Products
30
Complaints, Recall, Rejection & Re-Process of Material
Rework Procedure ….!!!
(SOP#CDPL/SOP/QA/048/04)
31
Complaints, Recall, Rejection & Re-Process of Material
Introducing an intermediate or API that does not conform to standards or specifications to one or more
processing steps that are different from the established manufacturing process to obtain acceptable quality
intermediate or API (e.g. recrystallizing with a different solvent).
Re-work
32
Complaints, Recall, Rejection & Re-Process of Material
Any batch of intermediate or finished product is rejected, after completion of the investigation as per
the SOP OF handling of out of specification (CDPL/SOP/QA/013), a decision is made to rework by QA.
If a decision is made to re-work the batch, a “Notification of Re-work” (CDPL/FR/QA/107) is initiated by
Production In-charge.
The reworked batches may be released for commercial purpose. If the quality of such batches is similar
to the normal production batches and results of stability are satisfactory.
If there is only one batch to be reworked , then an interim report will be prepared and the batch
released, if it is acceptable.
Impurity profile of re-worked batches shall be compared with validation batches.
Re-work of rejected Intermediates / Finished Products:
33
Complaints, Recall, Rejection & Re-Process of Material